Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.

Pahor M, Psaty BM, Alderman MH, Applegate WB, Williamson JD, Furberg CD.

Diabetes Care. 2000 Jul;23(7):888-92.

2.

New evidence on the prevention of cardiovascular events in hypertensive patients with type 2 diabetes.

Pahor M, Psaty BM, Furberg CD.

J Cardiovasc Pharmacol. 1998;32 Suppl 2:S18-23. Review.

PMID:
9736437
3.

What have we learned from the current trials?

Abbott KC, Bakris GL.

Med Clin North Am. 2004 Jan;88(1):189-207. Review.

PMID:
14871059
4.
5.

Antihypertensive treatment of patients with diabetes and hypertension.

Julius S, Majahalme S, Palatini P.

Am J Hypertens. 2001 Nov;14(11 Pt 2):310S-316S. Review.

PMID:
11721889
7.

Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers especially useful for cardiovascular protection?

Ong HT.

J Am Board Fam Med. 2009 Nov-Dec;22(6):686-97. doi: 10.3122/jabfm.2009.06.090094. Review.

8.

High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal?

Grossman E, Messerli FH, Goldbourt U.

Arch Intern Med. 2000 Sep 11;160(16):2447-52. Review.

PMID:
10979055
9.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

10.
11.
12.
13.
14.

Are angiotensin-converting enzyme inhibitors the best treatment for hypertension in type 2 diabetes?

Komers R, Anderson S.

Curr Opin Nephrol Hypertens. 2000 Mar;9(2):173-9. Review.

PMID:
10757223
15.

Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers.

Nosadini R, Tonolo G.

J Am Soc Nephrol. 2002 Nov;13 Suppl 3:S216-23. Review.

16.

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.

Matchar DB, McCrory DC, Orlando LA, Patel MR, Patel UD, Patwardhan MB, Powers B, Samsa GP, Gray RN.

Ann Intern Med. 2008 Jan 1;148(1):16-29. Epub 2007 Nov 5. Review.

PMID:
17984484
17.

Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.

Wu HY, Huang JW, Lin HJ, Liao WC, Peng YS, Hung KY, Wu KD, Tu YK, Chien KL.

BMJ. 2013 Oct 24;347:f6008. doi: 10.1136/bmj.f6008. Review.

18.

Treatment of hypertension in patients with diabetes: lessons from recent trials.

Agarwal R.

Cardiol Rev. 2001 Jan-Feb;9(1):36-44. Review.

PMID:
11174914
19.

Angiotensin-converting enzyme inhibitors and stroke risk: benefit beyond blood pressure reduction?

Hilleman DE, Lucas BD Jr.

Pharmacotherapy. 2004 Aug;24(8):1064-76. Review.

PMID:
15338854
20.

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.

PMID:
16259523

Supplemental Content

Support Center